Anna Falk-Delgado

  • Citations Per Year
Learn More
BACKGROUND AND PURPOSE Intravenous thrombolysis with tissue plasminogen activator is standard treatment in acute stroke today. The benefit of endovascular treatment has been questioned. Recently, studies evaluating endovascular treatment and intravenous thrombolysis compared with intravenous thrombolysis alone, have reported improved outcome for the(More)
  • 1